Company Profile

ERIS LIFESCIENCES LTD.

NSE : ERISBSE : 540596ISIN CODE : INE406M01024Industry : Pharmaceuticals & DrugsHouse : Private
BSE426.80-13.8 (-3.13 % )
PREV CLOSE (Rs.) 440.60
OPEN PRICE (Rs.) 439.00
BID PRICE (QTY) 425.20 (5 )
OFFER PRICE (QTY) 426.35 (6 )
VOLUME 460
TODAY'S LOW / HIGH (Rs.)420.10 439.00
52 WK LOW / HIGH (Rs.)438 798.8
NSE424.45 -17.35 (-3.93 % )
PREV CLOSE(Rs.) 441.80
OPEN PRICE (Rs.) 441.80
BID PRICE (QTY) 424.45 (2 )
OFFER PRICE (QTY) 425.35 (1 )
VOLUME 7985
TODAY'S LOW / HIGH(Rs.) 419.05 444.05
52 WK LOW / HIGH (Rs.)437 786

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 1.96328
Dividend Yield(%)
TTM EPS (Rs.)
P/E Ratio
Book Value (Rs.)
Face Value (Rs.)
MCap (Rs. in Mn)
Price/Earning (TTM)
Price/Sales (TTM)
Price/Book (MRQ)
PAT Margin (%) 38.61
ROCE (%) 35.45
Incorporation Year : 2007

Management Info :

- Chairman Amit Indubhushan Bakshi - Managing Director

Registered Office :

Address : 8th Floor, Commerce House I V,Beside Shell Petrol Pump,100 Feet Road, Prahladnagar,
Ahmedabad,
Gujarat-380015

Phone : 079 3045 1111

Website : www.eris.co.in

Registrar's Details : Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS More
02Jul07-02-2019$Eris Lifesciences partners with PlexusMD Eris Lifesciences partners w

Eris Lifesciences has entered into a partnership with PlexusMD, a healthcare networking platform, to offer artificial intelligence-powered learning platform 'Saarthi' to doctors in India.

The aim of the endeavour is to enable Indian physicians stay connected with global developments and practise evidence-based medicine to improve patient health outcomes.

Eris Lifesciences is engaged in manufacturing, marketing and selling of branded generics within the chronic and acute categories of the Indian Pharmaceutical Market.

Eris Lifesciences has entered into a partnership with PlexusMD,..
24Jun06-24-2019$ Board to consider Buyback of equity shares Board to consider Buyback o
Eris Lifesciences Ltd has informed BSE that the Board of Directors will consider a proposal of buyback of the fully paid-up equity shares of the Company of face value of Re. 1/- each at its meeting scheduled to be held on July 03, 2019. Further, pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 and Policy on ?Code of Conduct to Regulate, Monitor and Report Trading by its Designated Persons and immediate relatives of Designated Persons of the Company', the Trading Window of the Company shall remain closed from June 25, 2019 to July 05, 2019 (Both Days Inclusive).
Eris Lifesciences Ltd has informed BSE that the Board of Direct..
17Jun06-17-2019$Eris Lifesciences informs about company updates Eris Lifesciences informs ab

As per the requirements of Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Eris Lifesciences has informed that it has enclosed the details of the related party transactions on a consolidated basis for the year ended 31st March, 2019 in accordance with the format prescribed in the relevant accounting standards.

The above information is a part of company’s filings submitted to BSE.

As per the requirements of Regulation 23(9) of the SEBI (Listin..
12Jun06-12-2019$Eris Lifesciences informs about analyst meet Eris Lifesciences informs ab

Eris Lifesciences has informed about schedule of Analyst / Institutional Investor Meeting.

The above information is a part of company’s filings submitted to BSE.

Eris Lifesciences has informed about schedule of Analyst / Inst..
31May05-31-2019$Eris Lifesciences informs about analyst meet Eris Lifesciences informs ab

Eris Lifesciences has informed that the Analyst / Institutional Investor Meetings will be scheduled on Friday, 31st May, 2019 a Mumbai.

The above information is a part of company’s filings submitted to BSE.








Eris Lifesciences has informed that the Analyst / Institutional..
Financials More
Rs. in Millions
QTR Mar 19 ANNUAL 19
Net Profit524.162853.81
Gross Profit 591.02 3117.76
Operating Profit 735.23661.58
Net Sales 1984.38965.39
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Sanofi India (BSE)
 5936.60 (0.39%)
M.Cap ( in Cr)
13806.86
Fredun Pharma (BSE)
 405.00 (3.89%)
M.Cap ( in Cr)
161.58
Everest Organics (BSE)
 157.30 (4.87%)
M.Cap ( in Cr)
126.08
Natco Pharma (BSE)
 511.25 (0.96%)
M.Cap ( in Cr)
9293.50
Denis Chem Lab (BSE)
 42.00 (8.95%)
M.Cap ( in Cr)
53.49
Shareholding Pattern More
PROMOTERS 56.23 %
NON-INSTITUTION 24.13 %
MUTUAL FUNDS/UTI 11.12 %
FI/BANKS/INSURANCE 0 %
GOVERNMENT 0 %
FII 0 %
F & O Quotes